Page last updated: 2024-12-07
9-aminoellipticine
Description
9-Aminoellipticine is a synthetic ellipticine derivative that exhibits potent antitumor activity. It is an intercalating agent that binds to DNA, inhibiting DNA replication and transcription. The compound's synthesis involves several steps starting from ellipticine, a natural product isolated from the plant *Ochrosia grandiflora*. 9-aminoellipticine has shown promising preclinical results against various types of cancer, including leukemia, lung cancer, and breast cancer. It is studied because of its unique mechanism of action and its potential as a novel anticancer drug. However, its clinical development has been limited due to toxicity concerns.'
9-aminoellipticine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 99172 |
SCHEMBL ID | 3342543 |
MeSH ID | M0115579 |
Synonyms (16)
Synonym |
nsc 191345 |
icig 1089 |
6h-pyrido(4,3-b)carbazol-9-amine, 5,11-dimethyl- |
brn 0754366 |
5,11-dimethyl-6h-pyrido(4,3-b)carbazol-9-amine |
ccris 6481 |
6h-pyrido[4,3-b]carbazol-9-amine, 5,11-dimethyl- |
nsc191345 |
nsc-191345 |
9-aminoellipticine |
54779-53-2 |
5,11-dimethyl-6h-pyrido[4,3-b]carbazol-9-amine |
SCHEMBL3342543 |
DTXSID30970101 |
aminoellipticine, 9- |
626V38C3NM |
Research
Studies (15)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 8 (53.33) | 18.7374 |
1990's | 7 (46.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.65
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.65 (24.57) | Research Supply Index | 2.77 (2.92) | Research Growth Index | 4.43 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 15 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |